Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.0152 | 42 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.9426 | 41 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.95033 | 41 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.85451 | 40 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.91962 | 42 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.0475 | 41 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.0791 | 44 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.91978 | 40 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.9367 | 42 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.9495 | 42 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.93584 | 41 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.93965 | 42 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.9559 | 41 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.94781 | 41 |